Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Warby ParkerWRBY -0.19%68 Days Payable is 36.15 as of Jun. 2026, which is 1% below its 10-year median of 36.69. GuruFocus rates WRBY with a GF Score™ of 68/100 and a GF Value™ of $21.61 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Warby Parker ranks worse than 88.69% on this metric.
The historical data trend for Warby Parker's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Warby Parker's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Warby Parker Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Warby Parker's Days Payable distribution charts can be found below:
* The bar in red indicates where Warby Parker's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Warby Parker's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Warby Parker (WRBY) has a Days Payable of 36.15 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Warby Parker and its competitors. This is near median its historical median of 36.69. Over the past decade, Warby Parker's Days Payable has ranged from 24.36 to 92.41. According to the industry distribution chart, Warby Parker ranks #706 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 88.7%.
Is Warby Parker's Days Payable too high?
Warby Parker's current Days Payable of 36.15 is near median its 10-year median of 36.69. Over the past 10 years, this metric has ranged from a low of 24.36 to a high of 92.41. The Medical Devices & Instruments industry median Days Payable is 68.04. Warby Parker's value of 36.15 is 46.9% below this industry median. Based on the distribution chart, Warby Parker ranks #706 out of 796 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Warby Parker has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Warby Parker's Days Payable compare to XRAY and LMAT?
According to the Medical Devices & Instruments industry distribution chart, Warby Parker ranks #706 out of 796 companies for Days Payable. This places Warby Parker in the lower half of its industry. The industry median Days Payable is 68.04. Warby Parker's value of 36.15 is 46.9% below this benchmark. Historically, Warby Parker's own Days Payable has ranged from 24.36 to 92.41 over the past decade. While the company's 10-year median is 36.69 vs. the industry median of 68.04, Warby Parker has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.04, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Warby Parker's current Days Payable of 36.15 is 46.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Warby Parker and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Warby Parker's current Days Payable is 36.15, which is near median its own 10-year median of 36.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Warby Parker stock overvalued right now?
Based on GuruFocus' analysis, Warby Parker (WRBY) is currently considered Modestly Overvalued. The stock's GF Value™ is $21.61, compared to a current price of $26.41 — trading 22.2% above its estimated fair value. The current Days Payable is 36.15, which is near median its 10-year median of 36.69 and 46.9% below the Medical Devices & Instruments industry median of 68.04. Warby Parker's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Warby Parker (WRBY), the current Days Payable is 36.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Warby Parker (WRBY) Overvalued in 2026?
Based on GuruFocus' analysis, Warby Parker stock appears to be overvalued.
The current stock price of $26.41 is trading 22.2% above its estimated GF Value™ of $21.61.
GuruFocus considers Warby Parker to be Modestly Overvalued.
Key valuation signals for WRBY:
Days Payable: 36.15 (near median its 10-year median of 36.69)
GF Value™: $21.61 vs. price of $26.41 (22.2% above fair value)
Industry Position: 46.9% below the Medical Devices & Instruments median (#706 of 796)
No single metric tells the full story. See the WRBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
68GF Score
Get the complete analysis for WRBY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WRBY has been successfully added to your 
